Walleye Trading »

C4 Therapeutics shares owned by Walleye Trading

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Walleye Trading from 13F filings

Historical chart of Walleye Trading investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Walleye Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Walleye Trading

Quarter filed Position value Share count Share price at filing
2024-03-31 $221k 27k 8.17

More positions owned by Walleye Trading

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Call Option (NVDA)
Meta Platforms Cl A (META)
Amazon Call Option (AMZN)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Tesla Motors (TSLA)
Microstrategy Cl A New Put Option (MSTR)
Qualcomm Put Option (QCOM)
Broadcom Call Option (AVGO)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Coinbase Global Com Cl A Call Option (COIN)

View all positions for Walleye Trading

Top funds holding C4 Therapeutics

State Street Corporation
RA Capital Management
Daniel D. Thurber
Lynx1 Capital Management
Commodore Capital
Vanguard Group
Soleus Capital Management
Balyasny Asset Management
T. Rowe Price Associates
Bank of America Corporation
Silverarc Capital Management
Two Sigma Advisers
Arrowpoint Asset Management
Goldman Sachs Group
TCG Crossover Management

View all funds holding C4 Therapeutics